ArticleTransfusion2020
It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4.
Article in Transfusion, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Prevalence of Serologic Weak D Phenotype in Iranian Blood Donors: A Nationwide Retrospective Cross-Sectional Study.Health science reports · 2026Article
- On the Differentiation of Auto- and Allo-Anti-D: The Significance of DAT and Autocontrol.Iranian journal of pathology · 2026Article
- Novel RHD*49C allele identified in a prenatal patient.Transfusion · 2026Article
- Genetic diversity of the RHD gene in blood donors from the Brazilian Central-West.Hematology, transfusion and cell therapy · 2026Article
- A novel RHD allele (c.727 T>G) associated with reduced D antigen expression in a pregnant Chinese woman.Vox sanguinis · 2026Article
- A serologic weak D expressed by a combined weak D type 1/41.0.1 allele.Transfusion · 2026Article
- Rhesus Box as the Primary Mechanism of RHD Gene Deletion in RhD-Negative Blood Donors from Eastern Iran.International journal of hematology-oncology and stem cell research · 2026Article
- Asian-type DEL among D-negative patients and donors in Malaysia can ease the demand for D-negative red cells and RhIG.Blood global hematology · 2025Article
- A novel RHD allele combining partial D (c.455A>C) and weak D (c.1154G>C) variants.Transfusion · 2025Article
- IntegratingMedicina (Kaunas, Lithuania) · 2025Article
- A Bioinformatically Initiated Approach to Evaluate GATA1 Regulatory Regions in Samples with Weak D, Del, or D- Phenotypes Despite NormalTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2024Article
- Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).Annals of laboratory medicine · 2024Review
- Rh flow cytometry: An updated methodology for D antigen density applied to weak D types 164 and 165.Transfusion · 2023Article
- Article
- RHD genotyping to resolve weak and discrepant RhD patient phenotypes.Transfusion · 2022Article
- Transfusion support for a woman withImmunohematology · 2022Article
- DEL in China: the D antigen among serologic RhD-negative individuals.Journal of translational medicine · 2021Review
- Rh antibodies as a result of altered Rh epitopes on transfused red cells: a case series of seven Brazilian patients.Blood transfusion = Trasfusione del sangue · 2021Article
- Proceed with care: the "uncommon" serologic weak D phenotypes.Blood transfusion = Trasfusione del sangue · 2021Article
- What constitutes the most cautious approach for a pregnant person with weak D type 4.0?CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.